NLRP3 and Alzheimer disease: After injection of AAV9-siRNA-caspase-1, the behavior of AD mice in cognitive function experiments was alleviated, and the expressions of NLRP3, caspase-1, and GSDMD were down regulated in both cerebral cortex and hippocampus (Han et al., 2020).